HEADER TRANSFERASE 28-FEB-09 3GGJ TITLE HUMAN HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE IN COMPLEX WITH TITLE 2 9-(2-PHOSPHONOETHOXYETHYL)GUANINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HGPRTASE, HGPRT; COMPND 5 EC: 2.4.2.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPRT, HPRT1, HPT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SPHI606; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7-7 KEYWDS PURINE SALVAGE, ANTI-MALARIAL CHEMOTHERAPEUTIC, ACYCLIC NUCLEOSIDE KEYWDS 2 PHOSPHONATE, DISEASE MUTATION, GLYCOSYLTRANSFERASE, GOUT, MAGNESIUM, KEYWDS 3 METAL-BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.W.GUDDAT,D.T.KEOUGH,J.JERSEY REVDAT 3 01-NOV-23 3GGJ 1 REMARK REVDAT 2 13-JUL-11 3GGJ 1 VERSN REVDAT 1 18-AUG-09 3GGJ 0 JRNL AUTH D.T.KEOUGH,D.HOCKOVA,A.HOLY,L.M.NAESENS,T.S.SKINNER-ADAMS, JRNL AUTH 2 J.JERSEY,L.W.GUDDAT JRNL TITL INHIBITION OF HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE JRNL TITL 2 BY ACYCLIC NUCLEOSIDE PHOSPHONATES: A NEW CLASS OF JRNL TITL 3 ANTIMALARIAL THERAPEUTICS. JRNL REF J.MED.CHEM. V. 52 4391 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19527031 JRNL DOI 10.1021/JM900267N REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0066 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 12574 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 657 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 895 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2750 REMARK 3 BIN FREE R VALUE SET COUNT : 52 REMARK 3 BIN FREE R VALUE : 0.3660 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3289 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 110 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.411 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.318 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.992 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.865 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3402 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4611 ; 1.226 ; 1.994 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 423 ; 6.022 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 144 ;39.416 ;23.889 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 581 ;20.043 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;20.100 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 524 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2535 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2113 ; 0.973 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3403 ; 1.760 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1289 ; 1.196 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1206 ; 2.095 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 100 REMARK 3 ORIGIN FOR THE GROUP (A): 10.2470 46.1637 17.0790 REMARK 3 T TENSOR REMARK 3 T11: 0.1160 T22: 0.1424 REMARK 3 T33: 0.1283 T12: 0.0218 REMARK 3 T13: 0.0164 T23: 0.0296 REMARK 3 L TENSOR REMARK 3 L11: 0.6657 L22: 0.9642 REMARK 3 L33: 0.4733 L12: 0.0519 REMARK 3 L13: -0.2536 L23: -0.1726 REMARK 3 S TENSOR REMARK 3 S11: -0.0846 S12: 0.0335 S13: 0.1416 REMARK 3 S21: 0.0794 S22: 0.0246 S23: 0.0303 REMARK 3 S31: 0.1020 S32: -0.0237 S33: 0.0601 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 101 A 130 REMARK 3 ORIGIN FOR THE GROUP (A): 10.5152 66.5300 17.5438 REMARK 3 T TENSOR REMARK 3 T11: 0.0513 T22: 0.0085 REMARK 3 T33: 0.1771 T12: -0.0033 REMARK 3 T13: -0.0536 T23: -0.0148 REMARK 3 L TENSOR REMARK 3 L11: 1.8464 L22: 6.1922 REMARK 3 L33: 7.9117 L12: 0.3194 REMARK 3 L13: -2.2278 L23: -1.1848 REMARK 3 S TENSOR REMARK 3 S11: -0.0974 S12: 0.0317 S13: 0.2714 REMARK 3 S21: -0.5097 S22: 0.0672 S23: 0.1761 REMARK 3 S31: 0.1400 S32: -0.2343 S33: 0.0303 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 131 A 217 REMARK 3 ORIGIN FOR THE GROUP (A): 17.3584 54.9216 12.8509 REMARK 3 T TENSOR REMARK 3 T11: 0.0904 T22: 0.1324 REMARK 3 T33: 0.2748 T12: 0.0073 REMARK 3 T13: -0.0447 T23: 0.0433 REMARK 3 L TENSOR REMARK 3 L11: 0.0857 L22: 1.8284 REMARK 3 L33: 1.6265 L12: 0.1468 REMARK 3 L13: 0.0477 L23: 0.7404 REMARK 3 S TENSOR REMARK 3 S11: -0.0740 S12: 0.0191 S13: 0.1090 REMARK 3 S21: -0.1083 S22: 0.0342 S23: -0.2017 REMARK 3 S31: -0.0190 S32: -0.0228 S33: 0.0398 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 4 B 100 REMARK 3 ORIGIN FOR THE GROUP (A): 9.2728 25.4996 10.2346 REMARK 3 T TENSOR REMARK 3 T11: 0.1748 T22: 0.1574 REMARK 3 T33: 0.1182 T12: 0.0017 REMARK 3 T13: 0.0010 T23: 0.0089 REMARK 3 L TENSOR REMARK 3 L11: 0.2824 L22: 1.7060 REMARK 3 L33: 0.9167 L12: -0.4661 REMARK 3 L13: 0.4070 L23: -0.3497 REMARK 3 S TENSOR REMARK 3 S11: 0.0811 S12: -0.0003 S13: -0.0627 REMARK 3 S21: -0.3049 S22: -0.0151 S23: 0.0790 REMARK 3 S31: -0.0890 S32: 0.0936 S33: -0.0660 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 101 B 130 REMARK 3 ORIGIN FOR THE GROUP (A): 8.7284 4.6823 10.4721 REMARK 3 T TENSOR REMARK 3 T11: 0.2819 T22: 0.0533 REMARK 3 T33: 0.3467 T12: -0.0018 REMARK 3 T13: -0.0367 T23: -0.0077 REMARK 3 L TENSOR REMARK 3 L11: 0.1077 L22: 2.9115 REMARK 3 L33: 0.0990 L12: -0.3330 REMARK 3 L13: 0.0454 L23: -0.0397 REMARK 3 S TENSOR REMARK 3 S11: -0.0020 S12: -0.0560 S13: -0.0942 REMARK 3 S21: -0.4641 S22: -0.0001 S23: 0.3263 REMARK 3 S31: 0.0945 S32: -0.0558 S33: 0.0021 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 131 B 217 REMARK 3 ORIGIN FOR THE GROUP (A): 15.0727 16.3730 14.3130 REMARK 3 T TENSOR REMARK 3 T11: 0.1149 T22: 0.1007 REMARK 3 T33: 0.1618 T12: 0.0250 REMARK 3 T13: 0.0013 T23: 0.0089 REMARK 3 L TENSOR REMARK 3 L11: 0.2207 L22: 2.0214 REMARK 3 L33: 2.2418 L12: -0.1831 REMARK 3 L13: 0.3799 L23: 0.1982 REMARK 3 S TENSOR REMARK 3 S11: 0.1001 S12: -0.0233 S13: -0.0715 REMARK 3 S21: -0.2116 S22: 0.0623 S23: -0.1632 REMARK 3 S31: 0.1726 S32: 0.1338 S33: -0.1625 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3GGJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000051831. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13236 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 27.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : 0.12200 REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : 0.30000 REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3GEP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRATE, 10% ISO-PROPANOL, 29% REMARK 280 PEG 4000, 3.3MM INHIBITOR , PH 6.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 55.59450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.37700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 55.59450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.37700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 72.75400 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 274 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 THR A 2 REMARK 465 ARG A 3 REMARK 465 ALA B 1 REMARK 465 THR B 2 REMARK 465 HIS B 59 REMARK 465 ASP B 107 REMARK 465 THR B 110 REMARK 465 GLY B 117 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 13 CG CD OE1 OE2 REMARK 470 CYS A 22 SG REMARK 470 MET A 94 CG SD CE REMARK 470 TYR A 104 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 CYS A 105 SG REMARK 470 GLN A 108 CG CD OE1 NE2 REMARK 470 LEU A 121 CB CG CD1 CD2 REMARK 470 GLU A 196 CG CD OE1 OE2 REMARK 470 CYS A 205 SG REMARK 470 ARG B 3 CG CD NE CZ NH1 NH2 REMARK 470 SER B 4 OG REMARK 470 GLU B 13 CG CD OE1 OE2 REMARK 470 CYS B 22 SG REMARK 470 HIS B 60 CG ND1 CD2 CE1 NE2 REMARK 470 MET B 94 CG SD CE REMARK 470 CYS B 105 SG REMARK 470 GLN B 108 CG CD OE1 NE2 REMARK 470 SER B 122 OG REMARK 470 ASN B 153 CG OD1 ND2 REMARK 470 ARG B 169 CB CG CD NE CZ NH1 NH2 REMARK 470 VAL B 171 CG1 CG2 REMARK 470 TYR B 173 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 174 CG CD CE NZ REMARK 470 CYS B 205 SG REMARK 470 LYS B 216 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB ASN A 195 O HOH A 278 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 133 CD GLU B 133 OE2 0.081 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 12 -105.89 -51.54 REMARK 500 PRO A 14 -95.70 -42.60 REMARK 500 GLU A 32 -66.84 -98.20 REMARK 500 ILE A 61 129.53 67.23 REMARK 500 LYS A 68 -81.00 -90.31 REMARK 500 ASN A 106 -90.28 58.46 REMARK 500 ASP A 107 28.30 -165.07 REMARK 500 ASP A 120 75.83 -0.74 REMARK 500 ASP A 137 -93.24 -114.88 REMARK 500 ASN A 153 81.98 33.83 REMARK 500 MET A 156 138.52 -179.40 REMARK 500 TYR A 190 -83.85 52.53 REMARK 500 SER B 4 87.49 95.85 REMARK 500 LYS B 68 -92.45 53.15 REMARK 500 ASP B 119 152.01 65.39 REMARK 500 ASP B 120 76.99 47.68 REMARK 500 ASP B 137 -84.70 -117.47 REMARK 500 LEU B 146 -76.63 -53.08 REMARK 500 VAL B 171 100.66 35.79 REMARK 500 TYR B 173 21.35 -153.99 REMARK 500 LYS B 174 122.13 4.99 REMARK 500 TYR B 190 -94.55 45.60 REMARK 500 TYR B 215 47.64 -91.00 REMARK 500 LYS B 216 -120.41 -10.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU B 67 LYS B 68 -144.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 25H A 218 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 25H B 218 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HMP RELATED DB: PDB REMARK 900 HUMAN HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE IN COMPLEX REMARK 900 WITH GMP REMARK 900 RELATED ID: 1Z7G RELATED DB: PDB REMARK 900 HUMAN HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE I REMARK 900 RELATED ID: 1D6N RELATED DB: PDB REMARK 900 HUMAN HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE IN COMPLEX REMARK 900 WITH HPP REMARK 900 RELATED ID: 1BZY RELATED DB: PDB REMARK 900 HUMAN HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE IN COMPLEX REMARK 900 WITH A TRANSITION STATE ANALOG REMARK 900 RELATED ID: 3GGC RELATED DB: PDB DBREF 3GGJ A 1 217 UNP P00492 HPRT_HUMAN 2 218 DBREF 3GGJ B 1 217 UNP P00492 HPRT_HUMAN 2 218 SEQRES 1 A 217 ALA THR ARG SER PRO GLY VAL VAL ILE SER ASP ASP GLU SEQRES 2 A 217 PRO GLY TYR ASP LEU ASP LEU PHE CYS ILE PRO ASN HIS SEQRES 3 A 217 TYR ALA GLU ASP LEU GLU ARG VAL PHE ILE PRO HIS GLY SEQRES 4 A 217 LEU ILE MET ASP ARG THR GLU ARG LEU ALA ARG ASP VAL SEQRES 5 A 217 MET LYS GLU MET GLY GLY HIS HIS ILE VAL ALA LEU CYS SEQRES 6 A 217 VAL LEU LYS GLY GLY TYR LYS PHE PHE ALA ASP LEU LEU SEQRES 7 A 217 ASP TYR ILE LYS ALA LEU ASN ARG ASN SER ASP ARG SER SEQRES 8 A 217 ILE PRO MET THR VAL ASP PHE ILE ARG LEU LYS SER TYR SEQRES 9 A 217 CYS ASN ASP GLN SER THR GLY ASP ILE LYS VAL ILE GLY SEQRES 10 A 217 GLY ASP ASP LEU SER THR LEU THR GLY LYS ASN VAL LEU SEQRES 11 A 217 ILE VAL GLU ASP ILE ILE ASP THR GLY LYS THR MET GLN SEQRES 12 A 217 THR LEU LEU SER LEU VAL ARG GLN TYR ASN PRO LYS MET SEQRES 13 A 217 VAL LYS VAL ALA SER LEU LEU VAL LYS ARG THR PRO ARG SEQRES 14 A 217 SER VAL GLY TYR LYS PRO ASP PHE VAL GLY PHE GLU ILE SEQRES 15 A 217 PRO ASP LYS PHE VAL VAL GLY TYR ALA LEU ASP TYR ASN SEQRES 16 A 217 GLU TYR PHE ARG ASP LEU ASN HIS VAL CYS VAL ILE SER SEQRES 17 A 217 GLU THR GLY LYS ALA LYS TYR LYS ALA SEQRES 1 B 217 ALA THR ARG SER PRO GLY VAL VAL ILE SER ASP ASP GLU SEQRES 2 B 217 PRO GLY TYR ASP LEU ASP LEU PHE CYS ILE PRO ASN HIS SEQRES 3 B 217 TYR ALA GLU ASP LEU GLU ARG VAL PHE ILE PRO HIS GLY SEQRES 4 B 217 LEU ILE MET ASP ARG THR GLU ARG LEU ALA ARG ASP VAL SEQRES 5 B 217 MET LYS GLU MET GLY GLY HIS HIS ILE VAL ALA LEU CYS SEQRES 6 B 217 VAL LEU LYS GLY GLY TYR LYS PHE PHE ALA ASP LEU LEU SEQRES 7 B 217 ASP TYR ILE LYS ALA LEU ASN ARG ASN SER ASP ARG SER SEQRES 8 B 217 ILE PRO MET THR VAL ASP PHE ILE ARG LEU LYS SER TYR SEQRES 9 B 217 CYS ASN ASP GLN SER THR GLY ASP ILE LYS VAL ILE GLY SEQRES 10 B 217 GLY ASP ASP LEU SER THR LEU THR GLY LYS ASN VAL LEU SEQRES 11 B 217 ILE VAL GLU ASP ILE ILE ASP THR GLY LYS THR MET GLN SEQRES 12 B 217 THR LEU LEU SER LEU VAL ARG GLN TYR ASN PRO LYS MET SEQRES 13 B 217 VAL LYS VAL ALA SER LEU LEU VAL LYS ARG THR PRO ARG SEQRES 14 B 217 SER VAL GLY TYR LYS PRO ASP PHE VAL GLY PHE GLU ILE SEQRES 15 B 217 PRO ASP LYS PHE VAL VAL GLY TYR ALA LEU ASP TYR ASN SEQRES 16 B 217 GLU TYR PHE ARG ASP LEU ASN HIS VAL CYS VAL ILE SER SEQRES 17 B 217 GLU THR GLY LYS ALA LYS TYR LYS ALA HET 25H A 218 20 HET 25H B 218 20 HETNAM 25H {2-[2-(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL) HETNAM 2 25H ETHOXY]ETHYL}PHOSPHONIC ACID HETSYN 25H 9-(2-PHOSPHONOETHOXYETHYL)GUANINE FORMUL 3 25H 2(C9 H14 N5 O5 P) FORMUL 5 HOH *110(H2 O) HELIX 1 1 ASP A 17 PHE A 21 5 5 HELIX 2 2 PRO A 24 ALA A 28 5 5 HELIX 3 3 PRO A 37 GLY A 57 1 21 HELIX 4 4 TYR A 71 ARG A 86 1 16 HELIX 5 5 ASP A 120 LEU A 124 5 5 HELIX 6 6 GLY A 139 GLN A 151 1 13 HELIX 7 7 SER A 208 TYR A 215 1 8 HELIX 8 8 ASP B 17 PHE B 21 5 5 HELIX 9 9 PRO B 24 ALA B 28 5 5 HELIX 10 10 PRO B 37 MET B 56 1 20 HELIX 11 11 GLY B 70 ARG B 86 1 17 HELIX 12 12 GLY B 139 GLN B 151 1 13 HELIX 13 13 SER B 208 TYR B 215 1 8 SHEET 1 A 7 VAL A 7 VAL A 8 0 SHEET 2 A 7 PHE A 177 ILE A 182 1 O GLU A 181 N VAL A 7 SHEET 3 A 7 MET A 156 LYS A 165 1 N SER A 161 O PHE A 177 SHEET 4 A 7 ASN A 128 ILE A 136 1 N ILE A 131 O ALA A 160 SHEET 5 A 7 VAL A 62 LEU A 67 1 N LEU A 64 O VAL A 132 SHEET 6 A 7 THR A 95 LEU A 101 1 O ASP A 97 N ALA A 63 SHEET 7 A 7 VAL A 115 GLY A 117 -1 O ILE A 116 N ARG A 100 SHEET 1 B 3 LEU A 31 ILE A 36 0 SHEET 2 B 3 VAL A 204 ILE A 207 -1 O VAL A 204 N PHE A 35 SHEET 3 B 3 VAL A 187 VAL A 188 -1 N VAL A 188 O CYS A 205 SHEET 1 C 6 VAL B 7 VAL B 8 0 SHEET 2 C 6 PHE B 177 ILE B 182 1 O GLU B 181 N VAL B 7 SHEET 3 C 6 MET B 156 LYS B 165 1 N LEU B 162 O PHE B 180 SHEET 4 C 6 ASN B 128 ILE B 136 1 N ILE B 136 O LYS B 165 SHEET 5 C 6 ILE B 61 LEU B 67 1 N VAL B 62 O ASN B 128 SHEET 6 C 6 THR B 95 ARG B 100 1 O ILE B 99 N LEU B 67 SHEET 1 D 3 LEU B 31 ILE B 36 0 SHEET 2 D 3 VAL B 204 ILE B 207 -1 O VAL B 204 N PHE B 35 SHEET 3 D 3 VAL B 187 VAL B 188 -1 N VAL B 188 O CYS B 205 SHEET 1 E 2 LYS B 102 TYR B 104 0 SHEET 2 E 2 ILE B 113 VAL B 115 -1 O VAL B 115 N LYS B 102 SITE 1 AC1 14 ASP A 107 THR A 110 ASP A 137 THR A 138 SITE 2 AC1 14 GLY A 139 LYS A 140 THR A 141 LYS A 165 SITE 3 AC1 14 LYS A 185 PHE A 186 VAL A 187 LEU A 192 SITE 4 AC1 14 HOH A 227 HOH A 267 SITE 1 AC2 13 ILE B 135 ASP B 137 THR B 138 GLY B 139 SITE 2 AC2 13 THR B 141 LYS B 165 LYS B 185 PHE B 186 SITE 3 AC2 13 VAL B 187 LEU B 192 ASP B 193 HOH B 219 SITE 4 AC2 13 HOH B 221 CRYST1 111.189 72.754 51.387 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008994 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013745 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019460 0.00000